nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—pancreatic cancer	0.52	1	CbGaD
Triamcinolone—BCHE—Irinotecan—pancreatic cancer	0.118	0.548	CbGbCtD
Triamcinolone—CYP3A4—Tamoxifen—pancreatic cancer	0.0235	0.109	CbGbCtD
Triamcinolone—CYP3A4—Erlotinib—pancreatic cancer	0.02	0.0923	CbGbCtD
Triamcinolone—CYP3A4—Irinotecan—pancreatic cancer	0.018	0.0834	CbGbCtD
Triamcinolone—CYP3A4—Docetaxel—pancreatic cancer	0.0132	0.0611	CbGbCtD
Triamcinolone—CYP3A4—Sunitinib—pancreatic cancer	0.0131	0.0608	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—pancreatic cancer	0.00984	0.0455	CbGbCtD
Triamcinolone—Infection—Irinotecan—pancreatic cancer	0.000275	0.00109	CcSEcCtD
Triamcinolone—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000275	0.00109	CcSEcCtD
Triamcinolone—Pruritus—Erlotinib—pancreatic cancer	0.000275	0.00109	CcSEcCtD
Triamcinolone—Discomfort—Fluorouracil—pancreatic cancer	0.000273	0.00109	CcSEcCtD
Triamcinolone—Purpura—Epirubicin—pancreatic cancer	0.000272	0.00108	CcSEcCtD
Triamcinolone—Shock—Irinotecan—pancreatic cancer	0.000272	0.00108	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—pancreatic cancer	0.000272	0.00108	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000271	0.00108	CcSEcCtD
Triamcinolone—Haemoglobin—Docetaxel—pancreatic cancer	0.000271	0.00108	CcSEcCtD
Triamcinolone—Rhinitis—Docetaxel—pancreatic cancer	0.00027	0.00107	CcSEcCtD
Triamcinolone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00027	0.00107	CcSEcCtD
Triamcinolone—Oedema—Gemcitabine—pancreatic cancer	0.00027	0.00107	CcSEcCtD
Triamcinolone—Haemorrhage—Docetaxel—pancreatic cancer	0.000269	0.00107	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000268	0.00107	CcSEcCtD
Triamcinolone—Infection—Gemcitabine—pancreatic cancer	0.000268	0.00107	CcSEcCtD
Triamcinolone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000268	0.00106	CcSEcCtD
Triamcinolone—Pharyngitis—Docetaxel—pancreatic cancer	0.000267	0.00106	CcSEcCtD
Triamcinolone—Body temperature increased—Sunitinib—pancreatic cancer	0.000266	0.00106	CcSEcCtD
Triamcinolone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000265	0.00105	CcSEcCtD
Triamcinolone—Oedema—Fluorouracil—pancreatic cancer	0.000265	0.00105	CcSEcCtD
Triamcinolone—Infection—Fluorouracil—pancreatic cancer	0.000263	0.00105	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—pancreatic cancer	0.000263	0.00104	CcSEcCtD
Triamcinolone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000261	0.00104	CcSEcCtD
Triamcinolone—Dizziness—Tamoxifen—pancreatic cancer	0.000259	0.00103	CcSEcCtD
Triamcinolone—Tachycardia—Fluorouracil—pancreatic cancer	0.000259	0.00103	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—pancreatic cancer	0.000259	0.00103	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—pancreatic cancer	0.000258	0.00103	CcSEcCtD
Triamcinolone—Dizziness—Erlotinib—pancreatic cancer	0.000257	0.00102	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000254	0.00101	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—pancreatic cancer	0.000252	0.001	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000251	0.000999	CcSEcCtD
Triamcinolone—Insomnia—Irinotecan—pancreatic cancer	0.00025	0.000996	CcSEcCtD
Triamcinolone—Cardiac arrest—Epirubicin—pancreatic cancer	0.00025	0.000994	CcSEcCtD
Triamcinolone—Vomiting—Tamoxifen—pancreatic cancer	0.000249	0.000993	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—pancreatic cancer	0.000249	0.00099	CcSEcCtD
Triamcinolone—Paraesthesia—Irinotecan—pancreatic cancer	0.000249	0.000989	CcSEcCtD
Triamcinolone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000248	0.000985	CcSEcCtD
Triamcinolone—Rash—Tamoxifen—pancreatic cancer	0.000247	0.000984	CcSEcCtD
Triamcinolone—Dermatitis—Tamoxifen—pancreatic cancer	0.000247	0.000984	CcSEcCtD
Triamcinolone—Vomiting—Erlotinib—pancreatic cancer	0.000247	0.000982	CcSEcCtD
Triamcinolone—Dyspnoea—Irinotecan—pancreatic cancer	0.000247	0.000982	CcSEcCtD
Triamcinolone—Headache—Tamoxifen—pancreatic cancer	0.000246	0.000978	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000246	0.000978	CcSEcCtD
Triamcinolone—Rash—Erlotinib—pancreatic cancer	0.000245	0.000974	CcSEcCtD
Triamcinolone—Dermatitis—Erlotinib—pancreatic cancer	0.000245	0.000973	CcSEcCtD
Triamcinolone—Insomnia—Gemcitabine—pancreatic cancer	0.000244	0.00097	CcSEcCtD
Triamcinolone—Dyspepsia—Irinotecan—pancreatic cancer	0.000244	0.00097	CcSEcCtD
Triamcinolone—Headache—Erlotinib—pancreatic cancer	0.000243	0.000968	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000243	0.000967	CcSEcCtD
Triamcinolone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000242	0.000963	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000242	0.000961	CcSEcCtD
Triamcinolone—Asthenia—Sunitinib—pancreatic cancer	0.000241	0.000959	CcSEcCtD
Triamcinolone—Arrhythmia—Docetaxel—pancreatic cancer	0.000241	0.000957	CcSEcCtD
Triamcinolone—Dyspnoea—Gemcitabine—pancreatic cancer	0.00024	0.000957	CcSEcCtD
Triamcinolone—Insomnia—Fluorouracil—pancreatic cancer	0.00024	0.000954	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—pancreatic cancer	0.000239	0.000952	CcSEcCtD
Triamcinolone—Fatigue—Irinotecan—pancreatic cancer	0.000239	0.00095	CcSEcCtD
Triamcinolone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000238	0.000947	CcSEcCtD
Triamcinolone—Pruritus—Sunitinib—pancreatic cancer	0.000238	0.000946	CcSEcCtD
Triamcinolone—Pain—Irinotecan—pancreatic cancer	0.000237	0.000942	CcSEcCtD
Triamcinolone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000236	0.000941	CcSEcCtD
Triamcinolone—Erythema—Docetaxel—pancreatic cancer	0.000234	0.000933	CcSEcCtD
Triamcinolone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000233	0.000929	CcSEcCtD
Triamcinolone—Nausea—Tamoxifen—pancreatic cancer	0.000233	0.000927	CcSEcCtD
Triamcinolone—Fatigue—Gemcitabine—pancreatic cancer	0.000232	0.000925	CcSEcCtD
Triamcinolone—Muscular weakness—Epirubicin—pancreatic cancer	0.000232	0.000922	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000231	0.000919	CcSEcCtD
Triamcinolone—Pain—Gemcitabine—pancreatic cancer	0.000231	0.000918	CcSEcCtD
Triamcinolone—Nausea—Erlotinib—pancreatic cancer	0.000231	0.000918	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—pancreatic cancer	0.00023	0.000916	CcSEcCtD
Triamcinolone—Dysgeusia—Docetaxel—pancreatic cancer	0.00023	0.000914	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—pancreatic cancer	0.000228	0.000909	CcSEcCtD
Triamcinolone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000228	0.000908	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—pancreatic cancer	0.000227	0.000903	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—pancreatic cancer	0.000227	0.000903	CcSEcCtD
Triamcinolone—Back pain—Docetaxel—pancreatic cancer	0.000227	0.000902	CcSEcCtD
Triamcinolone—Pain—Fluorouracil—pancreatic cancer	0.000227	0.000902	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—pancreatic cancer	0.000223	0.000885	CcSEcCtD
Triamcinolone—Dizziness—Sunitinib—pancreatic cancer	0.000222	0.000884	CcSEcCtD
Triamcinolone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000222	0.000884	CcSEcCtD
Triamcinolone—Body temperature increased—Irinotecan—pancreatic cancer	0.000219	0.000871	CcSEcCtD
Triamcinolone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000218	0.000869	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—pancreatic cancer	0.000218	0.000869	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000214	0.000853	CcSEcCtD
Triamcinolone—Vomiting—Sunitinib—pancreatic cancer	0.000214	0.00085	CcSEcCtD
Triamcinolone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000213	0.000848	CcSEcCtD
Triamcinolone—Rash—Sunitinib—pancreatic cancer	0.000212	0.000843	CcSEcCtD
Triamcinolone—Dermatitis—Sunitinib—pancreatic cancer	0.000212	0.000842	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—pancreatic cancer	0.000211	0.000841	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000211	0.000839	CcSEcCtD
Triamcinolone—Urticaria—Fluorouracil—pancreatic cancer	0.000211	0.000838	CcSEcCtD
Triamcinolone—Headache—Sunitinib—pancreatic cancer	0.000211	0.000838	CcSEcCtD
Triamcinolone—Syncope—Docetaxel—pancreatic cancer	0.00021	0.000837	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—pancreatic cancer	0.00021	0.000836	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—pancreatic cancer	0.00021	0.000836	CcSEcCtD
Triamcinolone—Body temperature increased—Fluorouracil—pancreatic cancer	0.00021	0.000834	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—pancreatic cancer	0.000207	0.000822	CcSEcCtD
Triamcinolone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000206	0.00082	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000206	0.000819	CcSEcCtD
Triamcinolone—Cough—Docetaxel—pancreatic cancer	0.000205	0.000814	CcSEcCtD
Triamcinolone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000204	0.000812	CcSEcCtD
Triamcinolone—Convulsion—Docetaxel—pancreatic cancer	0.000203	0.000808	CcSEcCtD
Triamcinolone—Hypertension—Docetaxel—pancreatic cancer	0.000202	0.000806	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—pancreatic cancer	0.000202	0.000804	CcSEcCtD
Triamcinolone—Myalgia—Docetaxel—pancreatic cancer	0.0002	0.000794	CcSEcCtD
Triamcinolone—Nausea—Sunitinib—pancreatic cancer	0.0002	0.000794	CcSEcCtD
Triamcinolone—Asthenia—Irinotecan—pancreatic cancer	0.000199	0.00079	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000198	0.000789	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—pancreatic cancer	0.000197	0.000783	CcSEcCtD
Triamcinolone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000195	0.000777	CcSEcCtD
Triamcinolone—Dry mouth—Docetaxel—pancreatic cancer	0.000195	0.000777	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000195	0.000777	CcSEcCtD
Triamcinolone—Asthenia—Gemcitabine—pancreatic cancer	0.000193	0.00077	CcSEcCtD
Triamcinolone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000191	0.000761	CcSEcCtD
Triamcinolone—Oedema—Docetaxel—pancreatic cancer	0.000191	0.000761	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—pancreatic cancer	0.000191	0.000761	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—pancreatic cancer	0.000191	0.00076	CcSEcCtD
Triamcinolone—Pruritus—Gemcitabine—pancreatic cancer	0.000191	0.000759	CcSEcCtD
Triamcinolone—Infection—Docetaxel—pancreatic cancer	0.00019	0.000756	CcSEcCtD
Triamcinolone—Shock—Docetaxel—pancreatic cancer	0.000188	0.000749	CcSEcCtD
Triamcinolone—Pruritus—Fluorouracil—pancreatic cancer	0.000188	0.000746	CcSEcCtD
Triamcinolone—Tachycardia—Docetaxel—pancreatic cancer	0.000187	0.000743	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—pancreatic cancer	0.000185	0.000736	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000184	0.00073	CcSEcCtD
Triamcinolone—Dizziness—Irinotecan—pancreatic cancer	0.000183	0.000728	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—pancreatic cancer	0.000183	0.000727	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—pancreatic cancer	0.000182	0.000725	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000182	0.000724	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—pancreatic cancer	0.000182	0.000723	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—pancreatic cancer	0.00018	0.000717	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—pancreatic cancer	0.000177	0.000703	CcSEcCtD
Triamcinolone—Vomiting—Irinotecan—pancreatic cancer	0.000176	0.0007	CcSEcCtD
Triamcinolone—Dizziness—Fluorouracil—pancreatic cancer	0.000175	0.000698	CcSEcCtD
Triamcinolone—Rash—Irinotecan—pancreatic cancer	0.000175	0.000695	CcSEcCtD
Triamcinolone—Dermatitis—Irinotecan—pancreatic cancer	0.000174	0.000694	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000174	0.000694	CcSEcCtD
Triamcinolone—Headache—Irinotecan—pancreatic cancer	0.000173	0.00069	CcSEcCtD
Triamcinolone—Insomnia—Docetaxel—pancreatic cancer	0.000173	0.000689	CcSEcCtD
Triamcinolone—Paraesthesia—Docetaxel—pancreatic cancer	0.000172	0.000684	CcSEcCtD
Triamcinolone—Vomiting—Gemcitabine—pancreatic cancer	0.000171	0.000682	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—pancreatic cancer	0.000171	0.000681	CcSEcCtD
Triamcinolone—Dyspnoea—Docetaxel—pancreatic cancer	0.000171	0.000679	CcSEcCtD
Triamcinolone—Rash—Gemcitabine—pancreatic cancer	0.00017	0.000677	CcSEcCtD
Triamcinolone—Dermatitis—Gemcitabine—pancreatic cancer	0.00017	0.000676	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000169	0.000672	CcSEcCtD
Triamcinolone—Headache—Gemcitabine—pancreatic cancer	0.000169	0.000672	CcSEcCtD
Triamcinolone—Vomiting—Fluorouracil—pancreatic cancer	0.000169	0.000671	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—pancreatic cancer	0.000169	0.000671	CcSEcCtD
Triamcinolone—Dyspepsia—Docetaxel—pancreatic cancer	0.000168	0.00067	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000168	0.000669	CcSEcCtD
Triamcinolone—Rash—Fluorouracil—pancreatic cancer	0.000167	0.000665	CcSEcCtD
Triamcinolone—Dermatitis—Fluorouracil—pancreatic cancer	0.000167	0.000665	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—pancreatic cancer	0.000167	0.000664	CcSEcCtD
Triamcinolone—Headache—Fluorouracil—pancreatic cancer	0.000166	0.000661	CcSEcCtD
Triamcinolone—Fatigue—Docetaxel—pancreatic cancer	0.000165	0.000656	CcSEcCtD
Triamcinolone—Nausea—Irinotecan—pancreatic cancer	0.000164	0.000654	CcSEcCtD
Triamcinolone—Pain—Docetaxel—pancreatic cancer	0.000164	0.000651	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—pancreatic cancer	0.000162	0.000646	CcSEcCtD
Triamcinolone—Nausea—Gemcitabine—pancreatic cancer	0.00016	0.000637	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—pancreatic cancer	0.000158	0.000629	CcSEcCtD
Triamcinolone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000158	0.000627	CcSEcCtD
Triamcinolone—Nausea—Fluorouracil—pancreatic cancer	0.000157	0.000627	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—pancreatic cancer	0.000155	0.000616	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—pancreatic cancer	0.000153	0.000609	CcSEcCtD
Triamcinolone—Body temperature increased—Docetaxel—pancreatic cancer	0.000151	0.000602	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—pancreatic cancer	0.00015	0.000598	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000147	0.000584	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—pancreatic cancer	0.000146	0.000582	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000143	0.00057	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—pancreatic cancer	0.000143	0.000568	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—pancreatic cancer	0.000142	0.000565	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—pancreatic cancer	0.000142	0.000564	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—pancreatic cancer	0.000142	0.000563	CcSEcCtD
Triamcinolone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000141	0.000561	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000139	0.000553	CcSEcCtD
Triamcinolone—Cough—Epirubicin—pancreatic cancer	0.000138	0.000549	CcSEcCtD
Triamcinolone—Asthenia—Docetaxel—pancreatic cancer	0.000137	0.000546	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—pancreatic cancer	0.000137	0.000545	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—pancreatic cancer	0.000137	0.000543	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000136	0.00054	CcSEcCtD
Triamcinolone—Pruritus—Docetaxel—pancreatic cancer	0.000135	0.000539	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—pancreatic cancer	0.000135	0.000536	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—pancreatic cancer	0.000133	0.000529	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—pancreatic cancer	0.000132	0.000525	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—pancreatic cancer	0.000132	0.000524	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—pancreatic cancer	0.000131	0.000523	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—pancreatic cancer	0.000131	0.000522	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000129	0.000514	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—pancreatic cancer	0.000129	0.000514	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000129	0.000512	CcSEcCtD
Triamcinolone—Infection—Epirubicin—pancreatic cancer	0.000128	0.00051	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—pancreatic cancer	0.000128	0.000508	CcSEcCtD
Triamcinolone—Shock—Epirubicin—pancreatic cancer	0.000127	0.000505	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—pancreatic cancer	0.000127	0.000505	CcSEcCtD
Triamcinolone—Dizziness—Docetaxel—pancreatic cancer	0.000127	0.000504	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—pancreatic cancer	0.000126	0.000503	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—pancreatic cancer	0.000126	0.000501	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000125	0.000497	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—pancreatic cancer	0.000125	0.000496	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—pancreatic cancer	0.000123	0.00049	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—pancreatic cancer	0.000122	0.000485	CcSEcCtD
Triamcinolone—Vomiting—Docetaxel—pancreatic cancer	0.000122	0.000484	CcSEcCtD
Triamcinolone—Rash—Docetaxel—pancreatic cancer	0.000121	0.00048	CcSEcCtD
Triamcinolone—Dermatitis—Docetaxel—pancreatic cancer	0.000121	0.00048	CcSEcCtD
Triamcinolone—Headache—Docetaxel—pancreatic cancer	0.00012	0.000477	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000119	0.000475	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—pancreatic cancer	0.000119	0.000475	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—pancreatic cancer	0.000119	0.000472	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000118	0.000468	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—pancreatic cancer	0.000117	0.000468	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—pancreatic cancer	0.000117	0.000465	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—pancreatic cancer	0.000117	0.000464	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—pancreatic cancer	0.000116	0.000461	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000115	0.000459	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—pancreatic cancer	0.000115	0.000458	CcSEcCtD
Triamcinolone—Nausea—Docetaxel—pancreatic cancer	0.000114	0.000452	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—pancreatic cancer	0.000114	0.000452	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—pancreatic cancer	0.000111	0.000443	CcSEcCtD
Triamcinolone—Pain—Epirubicin—pancreatic cancer	0.00011	0.000439	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000109	0.000433	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—pancreatic cancer	0.000108	0.00043	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000107	0.000427	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000106	0.000424	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000106	0.000423	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000105	0.000418	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—pancreatic cancer	0.000103	0.00041	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—pancreatic cancer	0.000103	0.000408	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—pancreatic cancer	0.000102	0.000406	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—pancreatic cancer	0.000102	0.000406	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—pancreatic cancer	9.84e-05	0.000392	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—pancreatic cancer	9.51e-05	0.000378	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—pancreatic cancer	9.49e-05	0.000378	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—pancreatic cancer	9.44e-05	0.000376	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	9.4e-05	0.00776	CbGpPWpGaD
Triamcinolone—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	9.4e-05	0.00776	CbGpPWpGaD
Triamcinolone—Asthenia—Epirubicin—pancreatic cancer	9.26e-05	0.000368	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—pancreatic cancer	9.13e-05	0.000363	CcSEcCtD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	8.83e-05	0.00729	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Doxorubicin—pancreatic cancer	8.8e-05	0.00035	CcSEcCtD
Triamcinolone—PTGS2—S1P1 pathway—VEGFA—pancreatic cancer	8.78e-05	0.00725	CbGpPWpGaD
Triamcinolone—Asthenia—Doxorubicin—pancreatic cancer	8.57e-05	0.000341	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—pancreatic cancer	8.54e-05	0.00034	CcSEcCtD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	8.49e-05	0.00701	CbGpPWpGaD
Triamcinolone—Pruritus—Doxorubicin—pancreatic cancer	8.45e-05	0.000336	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	8.42e-05	0.00696	CbGpPWpGaD
Triamcinolone—Vomiting—Epirubicin—pancreatic cancer	8.21e-05	0.000327	CcSEcCtD
Triamcinolone—Rash—Epirubicin—pancreatic cancer	8.14e-05	0.000324	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—pancreatic cancer	8.13e-05	0.000324	CcSEcCtD
Triamcinolone—Headache—Epirubicin—pancreatic cancer	8.09e-05	0.000322	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	7.99e-05	0.0066	CbGpPWpGaD
Triamcinolone—Dizziness—Doxorubicin—pancreatic cancer	7.9e-05	0.000314	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	7.75e-05	0.0064	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	7.69e-05	0.00636	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	7.67e-05	0.00634	CbGpPWpGaD
Triamcinolone—Nausea—Epirubicin—pancreatic cancer	7.67e-05	0.000305	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—pancreatic cancer	7.59e-05	0.000302	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—pancreatic cancer	7.53e-05	0.0003	CcSEcCtD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—pancreatic cancer	7.52e-05	0.00622	CbGpPWpGaD
Triamcinolone—Dermatitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000299	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—pancreatic cancer	7.48e-05	0.000298	CcSEcCtD
Triamcinolone—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	7.14e-05	0.0059	CbGpPWpGaD
Triamcinolone—Nausea—Doxorubicin—pancreatic cancer	7.09e-05	0.000282	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	6.79e-05	0.00561	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	6.68e-05	0.00552	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—pancreatic cancer	6.53e-05	0.0054	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—FUT8—pancreatic cancer	6.38e-05	0.00527	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—GADD45A—pancreatic cancer	6.3e-05	0.0052	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—HES1—pancreatic cancer	6.06e-05	0.005	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	6.04e-05	0.00499	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—SOD2—pancreatic cancer	5.82e-05	0.00481	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	5.63e-05	0.00465	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	5.54e-05	0.00458	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	5.24e-05	0.00433	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	5.05e-05	0.00417	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	5.03e-05	0.00415	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	4.99e-05	0.00412	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatic cancer	4.98e-05	0.00412	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	4.87e-05	0.00402	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatic cancer	4.77e-05	0.00394	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	4.75e-05	0.00392	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	4.72e-05	0.0039	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	4.68e-05	0.00387	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	4.64e-05	0.00383	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	4.55e-05	0.00376	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	4.52e-05	0.00373	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	4.44e-05	0.00367	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	4.43e-05	0.00366	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	4.37e-05	0.00361	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	4.37e-05	0.00361	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	4.36e-05	0.0036	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	4.33e-05	0.00358	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	4.29e-05	0.00354	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.28e-05	0.00353	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	4.08e-05	0.00337	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pancreatic cancer	4.07e-05	0.00336	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—PPARG—pancreatic cancer	4.01e-05	0.00332	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	3.98e-05	0.00329	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PCSK1—pancreatic cancer	3.9e-05	0.00322	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.89e-05	0.00322	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	3.88e-05	0.00321	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—RB1—pancreatic cancer	3.84e-05	0.00317	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	3.84e-05	0.00317	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	3.83e-05	0.00317	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	3.78e-05	0.00312	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	3.76e-05	0.0031	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	3.75e-05	0.00309	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.71e-05	0.00306	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.68e-05	0.00304	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	3.67e-05	0.00303	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN2A—pancreatic cancer	3.63e-05	0.003	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	3.56e-05	0.00294	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CHD3—pancreatic cancer	3.47e-05	0.00287	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	3.47e-05	0.00287	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatic cancer	3.47e-05	0.00287	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	3.35e-05	0.00276	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	3.34e-05	0.00276	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	3.32e-05	0.00274	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	3.29e-05	0.00272	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	3.21e-05	0.00266	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	3.16e-05	0.00261	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—RB1—pancreatic cancer	3.15e-05	0.0026	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.13e-05	0.00258	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	3.08e-05	0.00255	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	3.07e-05	0.00253	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NR5A2—pancreatic cancer	2.91e-05	0.0024	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PTEN—pancreatic cancer	2.89e-05	0.00239	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	2.83e-05	0.00233	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	2.8e-05	0.00231	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	2.72e-05	0.00224	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	2.65e-05	0.00219	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	2.64e-05	0.00218	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.53e-05	0.00209	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	2.51e-05	0.00207	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PRSS1—pancreatic cancer	2.49e-05	0.00206	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—STAT3—pancreatic cancer	2.46e-05	0.00203	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	2.46e-05	0.00203	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	2.44e-05	0.00202	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	2.4e-05	0.00198	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.39e-05	0.00198	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	2.34e-05	0.00193	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	2.32e-05	0.00191	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	2.29e-05	0.0019	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.29e-05	0.00189	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	2.28e-05	0.00189	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	2.27e-05	0.00188	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	2.27e-05	0.00187	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	2.21e-05	0.00182	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ARG2—pancreatic cancer	2.16e-05	0.00178	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.15e-05	0.00178	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—pancreatic cancer	2.13e-05	0.00176	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	2.11e-05	0.00174	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRSS1—pancreatic cancer	2.05e-05	0.00169	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ZNRF3—pancreatic cancer	2.05e-05	0.00169	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—GCG—pancreatic cancer	2.05e-05	0.00169	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	2.04e-05	0.00168	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	1.93e-05	0.0016	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TYMP—pancreatic cancer	1.89e-05	0.00156	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	1.87e-05	0.00155	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	1.87e-05	0.00154	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—DTX1—pancreatic cancer	1.85e-05	0.00153	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	1.84e-05	0.00152	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	1.83e-05	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	1.75e-05	0.00144	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PRSS1—pancreatic cancer	1.71e-05	0.00142	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MEN1—pancreatic cancer	1.67e-05	0.00138	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.63e-05	0.00135	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.59e-05	0.00131	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	1.58e-05	0.00131	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.57e-05	0.0013	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.56e-05	0.00129	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	1.55e-05	0.00128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—DTX4—pancreatic cancer	1.55e-05	0.00128	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	1.54e-05	0.00127	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.53e-05	0.00127	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GLP1R—pancreatic cancer	1.52e-05	0.00126	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	1.51e-05	0.00125	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPP2R5B—pancreatic cancer	1.51e-05	0.00125	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—DPYD—pancreatic cancer	1.5e-05	0.00124	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ARG2—pancreatic cancer	1.49e-05	0.00123	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	1.47e-05	0.00121	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HEY2—pancreatic cancer	1.45e-05	0.0012	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.42e-05	0.00118	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC2A2—pancreatic cancer	1.42e-05	0.00117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.41e-05	0.00116	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.4e-05	0.00116	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.39e-05	0.00114	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—EZH2—pancreatic cancer	1.38e-05	0.00114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.36e-05	0.00112	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	1.35e-05	0.00111	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HEY1—pancreatic cancer	1.35e-05	0.00111	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TYMP—pancreatic cancer	1.3e-05	0.00107	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	1.28e-05	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.27e-05	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.27e-05	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.25e-05	0.00103	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.24e-05	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAG2—pancreatic cancer	1.19e-05	0.000985	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.19e-05	0.000981	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.18e-05	0.000973	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MEN1—pancreatic cancer	1.18e-05	0.000971	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC2A2—pancreatic cancer	1.17e-05	0.000964	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SHH—pancreatic cancer	1.12e-05	0.000927	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IAPP—pancreatic cancer	1.11e-05	0.000915	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CD44—pancreatic cancer	1.1e-05	0.000909	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.08e-05	0.000894	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.08e-05	0.00089	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	1.08e-05	0.000889	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—HRAS—pancreatic cancer	1.07e-05	0.000888	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.07e-05	0.000886	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.07e-05	0.000882	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HSPA1B—pancreatic cancer	1.06e-05	0.000878	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GCG—pancreatic cancer	1.05e-05	0.000871	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.000865	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.05e-05	0.000865	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—DPYD—pancreatic cancer	1.03e-05	0.000851	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	1.01e-05	0.000838	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—STK11—pancreatic cancer	9.92e-06	0.000819	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC2A2—pancreatic cancer	9.78e-06	0.000808	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.68e-06	0.000799	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAG1—pancreatic cancer	9.52e-06	0.000786	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.34e-06	0.000771	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.31e-06	0.000769	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD44—pancreatic cancer	9.04e-06	0.000747	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HSPA1A—pancreatic cancer	8.97e-06	0.000741	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	8.94e-06	0.000739	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.84e-06	0.00073	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TYMS—pancreatic cancer	8.53e-06	0.000705	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.51e-06	0.000703	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	8.36e-06	0.00069	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	8.25e-06	0.000682	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CD44—pancreatic cancer	7.57e-06	0.000625	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.49e-06	0.000619	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	7.48e-06	0.000618	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.41e-06	0.000612	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GCG—pancreatic cancer	7.26e-06	0.0006	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SMAD4—pancreatic cancer	7.14e-06	0.00059	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—pancreatic cancer	7.06e-06	0.000583	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HES1—pancreatic cancer	6.97e-06	0.000576	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOE—pancreatic cancer	6.94e-06	0.000573	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—STK11—pancreatic cancer	6.82e-06	0.000564	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.57e-06	0.000542	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.49e-06	0.000536	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.41e-06	0.000529	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—pancreatic cancer	6.26e-06	0.000517	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—pancreatic cancer	6.11e-06	0.000504	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—pancreatic cancer	6.04e-06	0.000499	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TYMS—pancreatic cancer	5.87e-06	0.000485	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIF1A—pancreatic cancer	5.84e-06	0.000482	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TSC2—pancreatic cancer	5.83e-06	0.000481	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOE—pancreatic cancer	5.7e-06	0.000471	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.67e-06	0.000469	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—pancreatic cancer	5.5e-06	0.000455	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOTCH1—pancreatic cancer	5.26e-06	0.000435	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGF—pancreatic cancer	5.09e-06	0.00042	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—pancreatic cancer	4.8e-06	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOE—pancreatic cancer	4.77e-06	0.000394	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—pancreatic cancer	4.75e-06	0.000393	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.57e-06	0.000378	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—pancreatic cancer	4.52e-06	0.000374	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.52e-06	0.000373	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.5e-06	0.000372	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—pancreatic cancer	4.31e-06	0.000356	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.27e-06	0.000353	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—pancreatic cancer	4.16e-06	0.000344	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—pancreatic cancer	4.15e-06	0.000342	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—pancreatic cancer	4.02e-06	0.000332	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—pancreatic cancer	3.94e-06	0.000326	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—pancreatic cancer	3.79e-06	0.000313	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—pancreatic cancer	3.5e-06	0.000289	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—pancreatic cancer	3.41e-06	0.000281	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CD44—pancreatic cancer	3.31e-06	0.000273	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—pancreatic cancer	3.3e-06	0.000273	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GCG—pancreatic cancer	3.17e-06	0.000262	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SRC—pancreatic cancer	3.16e-06	0.000261	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—pancreatic cancer	3.05e-06	0.000252	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NRAS—pancreatic cancer	3.04e-06	0.000251	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—STK11—pancreatic cancer	2.98e-06	0.000246	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—pancreatic cancer	2.92e-06	0.000242	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—pancreatic cancer	2.85e-06	0.000236	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—pancreatic cancer	2.83e-06	0.000234	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—pancreatic cancer	2.82e-06	0.000233	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—pancreatic cancer	2.79e-06	0.000231	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGFR—pancreatic cancer	2.77e-06	0.000229	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—pancreatic cancer	2.62e-06	0.000216	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.56e-06	0.000212	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—pancreatic cancer	2.4e-06	0.000199	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—pancreatic cancer	2.39e-06	0.000197	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HRAS—pancreatic cancer	2.22e-06	0.000184	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOE—pancreatic cancer	2.09e-06	0.000172	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—pancreatic cancer	2.01e-06	0.000166	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—pancreatic cancer	1.96e-06	0.000162	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.88e-06	0.000155	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.82e-06	0.00015	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.65e-06	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—pancreatic cancer	1.64e-06	0.000136	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.44e-06	0.000119	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.43e-06	0.000118	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.25e-06	0.000103	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.79e-07	7.26e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.18e-07	5.93e-05	CbGpPWpGaD
